Blog

Over 116 million Americans, roughly 35% of the population, are aged 50 and over. And this will swell to 160 million by 2040, nearly 40% of the population. Preparing for this demographic revolution is a necessity for physicians who wish to better serve their patients’ needs in addition to growing their practice.

Many physicians are less familiar with dosing of male hormones in female patients. As a result, testosterone replacement in women is sometimes avoided by doctors when it could provide substantial improvements in female patients’ health.

30% of the US female population is postmenopausal. Clinical studies support what we’ve known all along: bioidentical hormone replacement therapy can significantly improve quality of life of postmenopausal women.

Clinical studies have shown that hormone replacement therapy is typically safer & more effective when it is administered subcutaneously. In this article we explore how HRT pellets can lead to better outcomes for your patients.